Literature DB >> 17267840

Genetic polymorphisms and spontaneous preterm birth.

Catherine S Gibson1, Alastair H MacLennan, Gustaaf A Dekker, Paul N Goldwater, James M Dambrosia, David J Munroe, Shirley Tsang, Claudia Stewart, Karin B Nelson.   

Abstract

OBJECTIVE: To examine whether selected genetic polymorphisms in the infant are associated with spontaneous preterm birth (less than 37 weeks) among children with or without later-diagnosed cerebral palsy.
METHODS: Exploratory case-control study investigating the relationship of gestational age at delivery to 31 single nucleotide polymorphisms measured in newborn screening bloodspots. Among all 443 children with later-diagnosed cerebral palsy born to white women in South Australia in 1986-1999, 234 were born after spontaneous onset of labor, and 108 of these were preterm (gestational age less than 37 weeks). The comparison group was 549 infants born after spontaneous onset of labor, of whom 147 were preterm. Distributions of genotypic frequencies were examined in preterm compared with term infants with and without cerebral palsy. Genotyping was performed using a Taqman assay.
RESULTS: In children without cerebral palsy, preterm birth after spontaneous onset of labor was more frequent in association with a variant of the beta2 adrenergic receptor gene (ADRB2 Q27E, P=.003), inducible nitric oxide synthase (iNOS or NOS2A, P=.042), or thrombomodulin (G127A, P=.006). Among children with cerebral palsy, preterm birth was associated with polymorphisms in genes for endothelial nitric oxide synthase (eNOS -922, P=.012), plasminogen activator inhibitor-2 (P=.015 and .019), and alpha adducin (ADD1, P=.047).
CONCLUSION: We confirm previous observations that variants of the beta adrenergic receptor and of nitric oxide synthase are associated with prematurity, and suggest that genetic variants of the placental antifibrinolytic plasminogen activator inhibitor-2, and thrombomodulin and alpha adducin may be contributors to risk of spontaneous preterm birth. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2007        PMID: 17267840     DOI: 10.1097/01.AOG.0000252712.62241.1a

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  23 in total

1.  Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes.

Authors:  Roberto Romero; Digna R Velez Edwards; Juan Pedro Kusanovic; Sonia S Hassan; Shali Mazaki-Tovi; Edi Vaisbuch; Chong Jai Kim; Tinnakorn Chaiworapongsa; Brad D Pearce; Lara A Friel; Jacquelaine Bartlett; Madan Kumar Anant; Benjamin A Salisbury; Gerald F Vovis; Min Seob Lee; Ricardo Gomez; Ernesto Behnke; Enrique Oyarzun; Gerard Tromp; Scott M Williams; Ramkumar Menon
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

Review 2.  Racial differences in nitric oxide-dependent vasorelaxation.

Authors:  Eugenia Mata-Greenwood; Dong-Bao Chen
Journal:  Reprod Sci       Date:  2008-01       Impact factor: 3.060

3.  California Very Preterm Birth Study: design and characteristics of the population- and biospecimen bank-based nested case-control study.

Authors:  Martin Kharrazi; Michelle Pearl; Juan Yang; Gerald N DeLorenze; Christopher J Bean; William M Callaghan; Althea Grant; Eve Lackritz; Roberto Romero; Glen A Satten; Hyagriv Simhan; Anthony R Torres; Jonna B Westover; Robert Yolken; Dhelia M Williamson
Journal:  Paediatr Perinat Epidemiol       Date:  2012-01-31       Impact factor: 3.980

4.  Physical activity and epigenetic biomarkers in maternal blood during pregnancy.

Authors:  Sylvia E Badon; Alyson J Littman; Kwun Chuen Gary Chan; Mahlet G Tadesse; Patricia L Stapleton; Theo K Bammler; Tanya K Sorensen; Michelle A Williams; Daniel A Enquobahrie
Journal:  Epigenomics       Date:  2018-10-16       Impact factor: 4.778

5.  Are cytochrome P450 CYP2C8 and CYP2C9 polymorphisms associated with ibuprofen response in very preterm infants?

Authors:  Xavier Durrmeyer; Shushanik Hovhannisyan; Yves Médard; Evelyne Jacqz-Aigrain; Fabrice Decobert; Jérome Barre; Corinne Alberti; Yannick Aujard; Claude Danan; Olivier Baud
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

6.  MTHFR genotype and colorectal adenoma recurrence: data from a double-blind placebo-controlled clinical trial.

Authors:  A Joan Levine; Kristin Wallace; Shirley Tsang; Robert W Haile; Fred Saibil; Dennis Ahnen; Bernard F Cole; Elizabeth L Barry; David J Munroe; Iqbal U Ali; Per Ueland; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

7.  NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans.

Authors:  Digna Rosa Velez; William F Hulme; Jamie L Myers; J Brice Weinberg; Marc C Levesque; Martin E Stryjewski; Eduardo Abbate; Rosa Estevan; Sara G Patillo; John R Gilbert; Carol D Hamilton; William K Scott
Journal:  Hum Genet       Date:  2009-07-03       Impact factor: 4.132

8.  Diverse evolutionary histories for beta-adrenoreceptor genes in humans.

Authors:  Rachele Cagliani; Matteo Fumagalli; Uberto Pozzoli; Stefania Riva; Giacomo P Comi; Federica Torri; Fabio Macciardi; Nereo Bresolin; Manuela Sironi
Journal:  Am J Hum Genet       Date:  2009-07-02       Impact factor: 11.025

9.  Localization of a major susceptibility locus influencing preterm birth.

Authors:  G Chittoor; V S Farook; S Puppala; S P Fowler; J Schneider; T D Dyer; S A Cole; J L Lynch; J E Curran; L Almasy; J W Maccluer; A G Comuzzie; D E Hale; R S Ramamurthy; D J Dudley; E K Moses; R Arya; D M Lehman; C P Jenkinson; B S Bradshaw; R A Defronzo; J Blangero; R Duggirala
Journal:  Mol Hum Reprod       Date:  2013-05-20       Impact factor: 4.025

10.  Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.

Authors:  Elizabeth L Barry; Leah B Sansbury; Maria V Grau; Iqbal U Ali; Shirley Tsang; David J Munroe; Dennis J Ahnen; Robert S Sandler; Fred Saibil; Jiang Gui; Robert S Bresalier; Gail E McKeown-Eyssen; Carol Burke; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-09-15       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.